| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to a pharmaceutical composition of 2,2′-di(pyridin-4-yl)-1H,1′H-5,5′-bibenzo[d]imidazole, as well as to using it in producing a drug for treating C. Difficile-associated diarrhoea (CDAD) by selective bacteriostatic and/or bactericidal activity on Clostridium difficile as compared to C. perfringens, Staphylococcus aureus, Enterococcus faecium, Enterococcus faecalis, Bacillus subtilis and Bacteroides fragilis. n EFFECT: what is prepared is the new pharmaceutical composition possessing effective biological properties. n 2 cl, 8 tbl, 8 ex |